Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia

Gelijkaardige items

• New strategies to target iron metabolism for the treatment of beta thalassemia
  door: Oikonomidou, Paraskevi Rea, et al.
  Gepubliceerd in: (2016)
• What can we learn from ineffective erythropoiesis in thalassemia?
  door: Oikonomidou, Paraskevi Rea, et al.
  Gepubliceerd in: (2017)
• Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia
  door: Schmidt, Paul J, et al.
  Gepubliceerd in: (2015)
• Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
  door: Guo, Shuling, et al.
  Gepubliceerd in: (2013)
• Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major
  door: Casu, Carla, et al.
  Gepubliceerd in: (2018)